CNS Pharmaceuticals

CNSPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.007 M

$4.11 -1.79%

Close of 6 Nov 2026

As of 6 Nov 2026, CNS Pharmaceuticals (CNSP) has a market capitalization of $6.01M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$16.0K

Loss-making

Shares outstanding

1,461,449

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#440FibroBiologicsFBLG$6.36M
#441Enveric BiosciencesENVB$6.36M
#442CNS PharmaceuticalsCNSP$6.01M
#443ExicureXCUR$5.83M
#444Bio Green Med SolutionBGMS$5.76M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of CNS Pharmaceuticals, worth $10.0K. Grants and option exercises are excluded.

Michal Fisher$10.0K
2,000 shares at $5.00 on 18 May 2026 · filed 18 Aug 2026

What if CNS Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$19,321,150

Per share 4,701,010× higher

Bitcoin $1.53T

$1,045,434

Per share 254,363× higher

Apple $5.02T

$3,432,062

Per share 835,051× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for CNS Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.